SB 17 doesn ’t address pressing prescription drug transparency issues for CA voters

California ’s SB 17 is one of a number of bills relating to prescription drug transparency around prescription medicine costs that are wending their way through U.S. statehouses.

Source: The Catalyst - August 30, 2017 Category: Pharmaceuticals Authors: Priscilla VanderVeer Source Type: news